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ABSTRACT - Background: Obstructive sleep apnea syndrome (OSAS) is a very important and prevalent disease, which is associat-
ed with a poor quality of life in many patients. Treatments for OSAS include surgery, Continuos Positive Air way Pressure, and an
intraoral mandibular repositioner (IOMR), but the tendency of sleep centers is to  emphasize the apnea index, neglecting quality
of life as treatment outcome. Objective: To verify to what extent treatment with an IOMR improves the OSAS patient’s quality of
life. Method: Eleven male patients aged 34 to 63 years (mean=49) with mild to moderate OSAS were evaluated using the Calgary
SAQLI questionnaire applied before and four weeks after treatment with an IOMR. The mandibular repositioners were manufac-
tured individually for each patient with acrylic polymer and equipped with a retentive device to maintain the mandible in a for-
ward position during sleep. Results: Excellent improvement in the quality of life was observed in five patients (45.5%) and excel-
lent improvement in symptoms in 10 (90.9%). Conclusion: The systematic use of the IOMR indicates a clear improvement in the
global quality of life as well as in the symptoms of patients with OSAS.
KEY WORDS: obstructive sleep apnea syndrome, intraoral mandibular repositioner, and quality of life.
Qualidade de vida em pacientes com síndrome de apnéia obstrutiva do sono tratados com reposicionador mandibu-
lar intra-oral
RESUMO - Contexto. A síndrome da apnéia obstrutiva do sono (SAOS) é importante e prevalente doença associada à má qualidade
de vida em muitos pacientes. Os tratamentos disponíveis incluem cirurgias, CPAP e o aparelho reposicionador mandibular intra-
oral (ARMIO). Muitos centros de distúrbios de sono valorizam apenas a redução do número de apnéias no tratamento da SAOS,
dando pouca atenção à qualidade de vida como desfecho do tratamento. Objetivo: Graduar melhora da qualidade de vida dos
pacientes com SAOS usando ARMIO. Método: O questionário Calgary SAQLI foi aplicado, antes e após, 4 semanas de tratamen-
to com ARMIO, a 11 pacientes masculinos, entre 34 e 63 anos de idade (média de 49 anos), com SAOS leve a moderada. ARMIOs
foram manufaturados com polímero acrílico e providos com retentivos para manter a mandíbula em posição anterior durante o
sono. Resultados: Observamos grande melhora na qualidade de vida em 5 pacientes (45,5%) e melhora dos sintomas em 10 (90,9%).
Conclusão: O uso do ARMIO associa-se principalmente à melhora dos sintomas, como também à melhora da qualidade de vida
global.
PALAVRAS-CHAVE: síndrome da apnéia obstrutiva do sono, aparelho reposicionador mandibular intra-oral, qualidade de vida.
The quality of life of modern humans is dependent on
socioeconomic, cultural and health factors. Disease, in addi-
tion to affecting the psychological and emotional state of the
individual, compromises family income, causing damage to edu-
cation, housing and social interaction1,2. Obstructive sleep
apnea syndrome (OSAS) is characterized by complete or par-
tial obstruction of the upper airways during sleep, mainly at
the level of the oropharynx, with repeated and prolonged
pauses of respiration and oxyhemoglobin desaturation fol-
lowed by arousal and resumption of respiration3,4. OSAS is
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associated with an increase in adipose tissue in the orophar-
ynx, tonsil hypertrophy, macroglossia and structural anomalies
such as stenosis of the oropharynx and retrognathia. Diurnal
symptoms of the disease include hypersomnia and memory
and attention impairment. OSAS has been suggested to cause
acute myocardial infarction, cerebral vascular accident and heart
failure, among others4. Patients with OSAS seeking medical care
report unwillingness to carry out daily tasks, irritability in res-
ponse to small difficulties and lack of sexual interest. The
report of the spouse, who in most cases accompanies the
patient, almost always consists of complaints about loud snor-
ing and respiratory arrest followed by sudden and agonizing
arousals. Many patients with OSAS are not aware of what is
happening during sleep, reporting only tiredness and daytime
hypersomnia. The report of the bedroom companion, togeth-
er with clinical signs and symptoms, leads to the diagnostic
suspicion of OSAS which is confirmed by polysomnography4,5.
OSAS disorganizes the relational life of the patient, affect-
ing his/her ability to maintain an adequate social life and neg-
atively influencing his/her quality of life1. Intraoral  devices have
been developed as an alternative treatment for OSAS, and so-
me studies have shown improvement in the quality of life of
patients who systematically use an intraoral device that posi-
tions the mandible anteriorly and increases the dimensions of
the collapsible region of the airways6-8. In addition to the cited
mandibular repositioners, other treatments available include
continuous positive airway pressure (CPAP) - the standard
treatment for severe apneas - and surgical procedures which,
however, have not yet been evaluated in high quality clinical
studies9,10. Intraoral mandibular repositioners (IOMR) have
been playing an important role in the treatment of patients with
mild to moderate OSAS, i.e., an apnea-hypopnea index (AHI)
of up to 30 events per hour of sleep4,11-13. In this respect, a cor-
rect indication of these appliances can result in great benefit
to the patient, reestablishing his/her health in a less aggres-
sive manner,with low costs and without the complications inher-
ent to surgical procedures. Therefore, we carried out the pres-
ent study to determine the effect of a mandibular repositioner
on the quality of life of patients with OSAS14.
METHOD
Eleven male patients with OSAS ranging in age from 34 to 63
years (mean: 49 years), with a medical indication for the use of a
mandibular repositioner based on a previous polysomnographic
study that showed an AHI below 30 events per hour, participated in
the study.
We used the Calgary Sleep Apnea Quality of Life Index (Calgary
SAQLI) - a disease-specific quality of life questionnaire - in which all
items influencing the quality of life of patients with OSAS were iden-
tified15,16.The Calgary SAQLI contains 35 questions organized in such
a way as to permit the assessment of five functional domains, i.e.,
daily routine, social interactions, emotional state, symptoms, and
side effects, in order to determine the possible negative influence of
treatment.
The Calgary SAQLI was applied to each patient on his/her first
visit to the dental office. Once the device was manufactured and
installed, the patient was instructed to use the mandibular reposi-
tioner for 4 weeks and the questionnaire was then reapplied.
The IOMR were manufactured using dental self-polymerizing
acrylic resin, and consisted of a resin plate for occlusal covering of
the upper arch and another occlusal plate for covering of the lower
arch. The plates were fitted with retentive clasps to guarantee fixa-
tion and stabilization of the mandible.The plates were connected by
a stainless steel mechanism that permitted advancement of the low-
er plate in relation to the upper plate in tens of millimeters.
After molding, manufacturing and installation of the device, the
patients were kept under weekly observation for 4 weeks, receiving
weekly assessment and adjustments, and the Calgary SAQLI question-
naire was again applied at the end of this period. In an additional fifth
session, the possible negative impacts of treatment on the quality of
life of each patient were determined.
Data analysis and interpretation 
The Calgary SAQLI provides two groups of values: one associat-
ed with pretreatment and the other with post-treatment, with the
difference between them (important minimum difference = IMD) being
considered for evaluation of the procedure.As standardized, an IMD
of 1.0 in the Calgary SAQLI questionnaire indicates improvement in
the quality of life15.A general IMD and an IMD for each domain were
then calculated. Improvement was scored as small (1.00 to 1.49), good
(1.50 to 1.99) and excellent (above 2.00).
RESULTS
Table 1. Percent improvement in the quality of life of patients with obstructive sleep apnea syndrome treated with an intraoral
mandibular repositioner as determined by the Calgary SAQLI questionnaire.
Improvement Global Daily Social Emotional Symptoms
result routine interactions state
Absent 0 0 1 (9.1%) 3 (27.2%) 0
Small 4 (36.3%) 2 (18.2%) 3 (27.2%) 3 (27.2%) 0
Good 2 (18.2%) 5 (45.5%) 3 (27.2%) 2 (18.2%) 3 (18.2%)
Excellent 5 (45.5%) 4 (36.3%) 4 (36.3%) 3 (27.2%) 8 (79.8%)
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According to the concept of the IMD, all patients of the
present study treated with the mandibular repositioner showed
small to excellent improvement according to our classification
when assessed by the Calgary SAQLI questionnaire.As shown
in Table 1, 4 (36.3%) of the 11 participants showed small
improvement, 2 (18.2%) good improvement, and 5 (45.5%)
excellent improvement, with none of the patients showing lack
of improvement.
Improvement was also observed for the daily routine
domain, with 4 (36.3%) patients showing excellent improve-
ment, 5 (45.5%) good improvement and 2 (18.2%) small
improvement. More than 80% of the patients reached good
to excellent improvement, with none of the patients showing
lack of  improvement in this domain.
With respect to social interactions, 4 patients (36.5%)
showed excellent improvement, 3 (27.2%) good improve-
ment, and 3 (27.2%) small improvement, while one patient
(9.1%) did not present any improvement.
Regarding emotional state, 3 (27.2%) patients showed
excellent improvement, 2 (18.2%) good improvement, and 3
(27.2%) small improvement, while no improvement in emo-
tional state was observed for 3 other patients.
The symptom domain yielded the most surprising results
and was probably the factor mainly responsible for the improved
quality of life observed for all patients treated with the
mandibular repositioner in the present study. Excellent improve-
ment was reached by 8 (79.8%) patients and good improve-
ment by 3 (18.2%) patients.
No side effects were reported by the patients using the
IOMR throughout the study period.
DISCUSSION
All patients of the present study showed some degree of
improvement in their quality of life upon global assessment.
Only 3 patients did not show improvement in specific domains
such as emotional state or social interaction, despite impro-
vement in the global score. These patients probably present-
ed other parallel clinical conditions contributing to OSAS such
as depression, anxiety, insomnia and periodic limb movement
syndrome, which were not the subject of the present investi-
gation4. With respect to the symptom domain, the excellent
improvement observed for this group of patients might have
been due to the marked reduction in the AHI as a result of the
use of the IOMR10.
There is no doubt that OSAS is associated with clinical, psy-
chological and social alterations, causing deterioration of the
health of patients in a subtle but incisive and long-lasting man-
ner, with the disorder not being easily detected. In this respect,
the Calgary SAQLI questionnaire has been shown to be an excel-
lent instrument for the determination of the quality of life of
patients with OSAS17,18.
Treatment of OSAS by CPAP, despite improving important
clinical parameters, does not always result in subjective ben-
efit to the patient, who often does not tolerate the treatment
itself, or the requirements and obstacles to live with a stigmati-
zing apparatus19. It should also be noted that, when thinking
about a global treatment, patients with an AHI 30/hour but
without symptoms of daytime sleepiness are poorly tolerant
to and compliant with CPAP, leading to discontinuous and re-
duced utilization of this treatment, a fact suggesting that
CPAP should not be indicated to these patients19.
The difficulty of treatment with CPAP, or subtreatment by
this modality might create a contingent of unsatisfied patients
and, even more important, of patients submitted to the con-
sequences of OSAS and falsely protected by a potentially
good, but restricted, therapy. The utilization of an IOMR by
Yoshida14 in a clinical study on 256 patients demonstrated
improved oxygen saturation, reduced duration of apneas,
increased sleep efficiency, and a reduction in total microarousals.
Compliance with the IOMR continued to be high (90%) even
after 2.5 years, clearly demonstrating that the mandibular
repositioner offers some advantages over other therapies, in
addition to its low cost, easy fabrication14, and the absence
of side effects, with excellent improvement in the quality of
life as shown in the present study.
Some authors still criticize the small number of studies ana-
lyzing the effects of OSAS on quality of life and of the response
to CPAP treatment. However, studies have demonstrated that
all quality of life aspects ranging from physical to emotional
health and social interaction are notably compromised by
OSAS and that CPAP therapy improves aspects related to
vitality, social interaction and mental health20,21.
As stated above, the main problem of patients treated with
CPAP might be related to the daily living with the equipment
and its side effects, with a large number of patients showing
up to 30 events per hour but with low daytime sleepiness indices
benefitting from the advent of the IOMR11,22. OSAS can by con-
trolled by these appliances in many patients, who no longer
require the obligatory use of CPAP but who use a more com-
fortable, less invasive device which is more versatile during
daily life and has fewer psychological repercussions, especial-
ly in young patients who feel disturbed by the daily depend-
ence on CPAP.
The results of the present study suggest that the IOMR effec-
tively improved the quality of life of patients with mild to mod-
erate OSAS. Based on the nature and aim of the treatments
available for OSAS, comparative clinical studies between CPAP
and IOMR are required, whose outcome does not only focus
on the apnea index but also on the quality of life of patients
with OSAS.
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